Carlsmed (CARL) Interest & Investment Income (2024 - 2026)

Carlsmed (CARL) has reported Interest & Investment Income for 3 consecutive years, with $839000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income rose 149.7% year-over-year to $839000.0; the trailing twelve-month figure through Jun 2026 stood at $3.7 million (up 144.21% YoY), and the FY2025 full-year result was $2.7 million, up 102.86% from the prior year.
• Interest & Investment Income eased to $839000.0 in Q2 2026 per CARL's latest filing, from $891000.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $1.0 million in Q4 2025 and bottomed at $336000.0 in Q2 2025.
• Historically, Interest & Investment Income has averaged $628888.9 across 3 years, with a median of $428000.0 in 2024.
• The widest YoY moves for Interest & Investment Income: up 150.73% in 2025, down 21.5% in 2025.
• Over 3 years, Interest & Investment Income stood at $410000.0 in 2024, then surged by 150.73% to $1.0 million in 2025, then dropped by 18.39% to $839000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $839000.0, $891000.0, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.